Twenty-month-old Vida Rodriguez is the reason her 7-year-old sister, Alessia, is playing at home — instead of lying in a ...
SOUTH SAN FRANCISCO, Calif., October 06, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company ™ – a leading precision medicine company focused on the discovery, development, and ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization ...
SOUTH SAN FRANCISCO - CareDx, Inc. (NASDAQ:CDNA), a healthcare diagnostics company with a market capitalization of $808 million and impressive gross margins of 67%, announced new innovations in ...
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company ™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value ...
MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...
Researchers report the first human test of an enzyme-converted A-type kidney to universal O, which if validated in future ...
WASHINGTON, DC – The American Association of Physicians of Indian Origin (AAPI) has launched a nationwide stem cell donor drive to expand the donor pool for Indian American patients. This initiative ...
SDSU and NDSU have established themselves as two of the top FCS programs in the country. They have battled for the Dakota ...
Covers low tumor burden “watch-and-wait” setting, an unmet medical needRegistrational Phase 3 watch-and-wait to start in 2026EO2463 has broad ...
The indolent lymphoma market is witnessing steady growth driven by the increasing prevalence of slow-growing non-Hodgkin ...